LU75242A1 - - Google Patents

Info

Publication number
LU75242A1
LU75242A1 LU75242A LU75242A LU75242A1 LU 75242 A1 LU75242 A1 LU 75242A1 LU 75242 A LU75242 A LU 75242A LU 75242 A LU75242 A LU 75242A LU 75242 A1 LU75242 A1 LU 75242A1
Authority
LU
Luxembourg
Application number
LU75242A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75242A1 publication Critical patent/LU75242A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU75242A 1975-06-25 1976-06-25 LU75242A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7519960A FR2315277A1 (fr) 1975-06-25 1975-06-25 Nouveaux derives pentacycliques, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
LU75242A1 true LU75242A1 (fr) 1978-01-18

Family

ID=9157046

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75242A LU75242A1 (fr) 1975-06-25 1976-06-25

Country Status (17)

Country Link
US (1) US4138489A (fr)
JP (1) JPS6039679B2 (fr)
AU (1) AU496905B2 (fr)
BE (1) BE843215A (fr)
CH (1) CH616425A5 (fr)
DE (1) DE2627190A1 (fr)
DK (1) DK285576A (fr)
ES (1) ES449209A1 (fr)
FR (1) FR2315277A1 (fr)
GB (1) GB1543807A (fr)
HU (1) HU174882B (fr)
IE (1) IE43138B1 (fr)
IL (1) IL49864A0 (fr)
LU (1) LU75242A1 (fr)
NL (1) NL7606884A (fr)
SE (1) SE420730B (fr)
ZA (1) ZA763779B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786426B (en) * 1977-11-25 1979-10-31 Scras New indulo(2,3-a)quinolizidines,preparation and therapeutic use
US4428877A (en) 1978-07-12 1984-01-31 Richter Gedeon Vegyeszeti Gyar Rt. Cis-10-bromo-E-homoeburnanes
JPH0523116Y2 (fr) * 1988-07-29 1993-06-14
IT1248881B (it) * 1989-06-21 1995-01-30 Richter Gedeon Vegyeszet Derivati diesteri di ottaidro-indolo/2,3-a/tetraidropiramil/2,3-c/ chinolizina racemici ed otticamente attivi e procedimento per la loro preparazione
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536725A (en) * 1967-11-22 1970-10-27 Miles Lab Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine
FR2168853B1 (fr) * 1972-01-24 1975-04-25 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
JPS5217488A (en) 1977-02-09
BE843215A (fr) 1976-12-21
DE2627190A1 (de) 1977-01-20
SE7607231L (sv) 1976-12-26
FR2315277B1 (fr) 1979-08-10
SE420730B (sv) 1981-10-26
NL7606884A (nl) 1976-12-28
GB1543807A (en) 1979-04-04
CH616425A5 (fr) 1980-03-31
FR2315277A1 (fr) 1977-01-21
HU174882B (hu) 1980-04-28
AU1523676A (en) 1978-01-05
AU496905B2 (en) 1978-11-09
JPS6039679B2 (ja) 1985-09-06
IL49864A0 (en) 1976-08-31
IE43138B1 (en) 1980-12-31
US4138489A (en) 1979-02-06
ES449209A1 (es) 1977-07-16
IE43138L (en) 1976-12-25
DK285576A (da) 1976-12-26
ZA763779B (en) 1977-06-29

Similar Documents

Publication Publication Date Title
FI762120A (fr)
FR2315847B3 (fr)
FR2323050B3 (fr)
JPS5755466B2 (fr)
JPS5314618B2 (fr)
JPS5229209U (fr)
JPS51110340U (fr)
JPS5225718U (fr)
JPS5257174Y2 (fr)
JPS5622563Y2 (fr)
JPS5528121Y2 (fr)
JPS537529Y2 (fr)
JPS5276852U (fr)
JPS51144597U (fr)
JPS5247056U (fr)
JPS5248926U (fr)
JPS5220541U (fr)
JPS50117309U (fr)
JPS5212421U (fr)
CH601857A5 (fr)
CH600933A5 (fr)
CH596797A5 (fr)
AU482296A (fr)
BG22246A2 (fr)
BG22273A1 (fr)